160 related articles for article (PubMed ID: 2564330)
1. Why must some schizophrenic patients be involuntarily committed? The role of insight.
McEvoy JP; Applebaum PS; Apperson LJ; Geller JL; Freter S
Compr Psychiatry; 1989; 30(1):13-7. PubMed ID: 2564330
[TBL] [Abstract][Full Text] [Related]
2. Long-term effects of involuntary hospitalization on medication adherence, treatment engagement and perception of coercion.
Jaeger S; Pfiffner C; Weiser P; Längle G; Croissant D; Schepp W; Kilian R; Becker T; Eschweiler G; Steinert T
Soc Psychiatry Psychiatr Epidemiol; 2013 Nov; 48(11):1787-96. PubMed ID: 23604621
[TBL] [Abstract][Full Text] [Related]
3. Differences in the nature of relapse and subsequent inpatient course between medication-compliant and noncompliant schizophrenic patients.
McEvoy JP; Howe AC; Hogarty GE
J Nerv Ment Dis; 1984 Jul; 172(7):412-6. PubMed ID: 6144721
[TBL] [Abstract][Full Text] [Related]
4. Improved insight affects social outcomes in involuntarily committed psychotic patients: a longitudinal study in the Netherlands.
van Baars AW; Wierdsma AI; Hengeveld MW; Mulder CL
Compr Psychiatry; 2013 Oct; 54(7):873-9. PubMed ID: 23618608
[TBL] [Abstract][Full Text] [Related]
5. Psychotic patients' understanding of informed consent.
Irwin M; Lovitz A; Marder SR; Mintz J; Winslade WJ; Van Putten T; Mills MJ
Am J Psychiatry; 1985 Nov; 142(11):1351-4. PubMed ID: 2865904
[TBL] [Abstract][Full Text] [Related]
6. Compliance and schizophrenia: the predictive potential of insight into illness, symptoms, and side effects.
Kao YC; Liu YP
Compr Psychiatry; 2010; 51(6):557-65. PubMed ID: 20965300
[TBL] [Abstract][Full Text] [Related]
7. Clinical characteristics of hospitalized psychotic patients who refuse antipsychotic drug therapy.
Zito JM; Routt WW; Mitchell JE; Roerig JL
Am J Psychiatry; 1985 Jul; 142(7):822-6. PubMed ID: 2861754
[TBL] [Abstract][Full Text] [Related]
8. Hospitalized schizophrenic patient views about seclusion.
Hammill K; McEvoy JP; Koral H; Schneider N
J Clin Psychiatry; 1989 May; 50(5):174-7. PubMed ID: 2715140
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of factors influencing medication compliance in inpatient treatment of psychotic disorders.
Janssen B; Gaebel W; Haerter M; Komaharadi F; Lindel B; Weinmann S
Psychopharmacology (Berl); 2006 Aug; 187(2):229-36. PubMed ID: 16710714
[TBL] [Abstract][Full Text] [Related]
10. [Disease models and change in attitude of involuntarily admitted schizophrenic patients].
Ullrich J; Ulmar G; Starzinski T
Fortschr Neurol Psychiatr; 1995 Dec; 63(12):480-6. PubMed ID: 8586351
[TBL] [Abstract][Full Text] [Related]
11. Attitudes toward antipsychotic medication: the impact of clinical variables and relationships with health professionals.
Day JC; Bentall RP; Roberts C; Randall F; Rogers A; Cattell D; Healy D; Rae P; Power C
Arch Gen Psychiatry; 2005 Jul; 62(7):717-24. PubMed ID: 15997012
[TBL] [Abstract][Full Text] [Related]
12. A 2-year follow-up of involuntary admission's influence upon adherence and outcome in first-episode psychosis.
Opjordsmoen S; Friis S; Melle I; Haahr U; Johannessen JO; Larsen TK; Røssberg JI; Rund BR; Simonsen E; Vaglum P; McGlashan TH
Acta Psychiatr Scand; 2010 May; 121(5):371-6. PubMed ID: 20085554
[TBL] [Abstract][Full Text] [Related]
13. Insight in schizophrenia. Its relationship to acute psychopathology.
McEvoy JP; Apperson LJ; Appelbaum PS; Ortlip P; Brecosky J; Hammill K; Geller JL; Roth L
J Nerv Ment Dis; 1989 Jan; 177(1):43-7. PubMed ID: 2562850
[TBL] [Abstract][Full Text] [Related]
14. Involuntary medication in psychiatric inpatient treatment.
Kaltiala-Heino R; Välimäki M; Korkeila J; Tuohimäki C; Lehtinen V
Eur Psychiatry; 2003 Oct; 18(6):290-5. PubMed ID: 14611924
[TBL] [Abstract][Full Text] [Related]
15. Patients' and psychiatrists' perceptions of clinical decisions during schizophrenia treatment.
Hamann J; Mendel RT; Fink B; Pfeiffer H; Cohen R; Kissling W
J Nerv Ment Dis; 2008 Apr; 196(4):329-32. PubMed ID: 18414128
[TBL] [Abstract][Full Text] [Related]
16. Insight: demographic differences and associations with one-year outcome in schizophrenia and schizoaffective disorder.
Wiffen BD; Rabinowitz J; Fleischhacker WW; David AS
Clin Schizophr Relat Psychoses; 2010 Oct; 4(3):169-75. PubMed ID: 20880827
[TBL] [Abstract][Full Text] [Related]
17. Effects of involuntary medication.
Am J Psychiatry; 1991 Nov; 148(11):1621-3. PubMed ID: 1681755
[No Abstract] [Full Text] [Related]
18. A large-scale validation study of the Medication Adherence Rating Scale (MARS).
Fialko L; Garety PA; Kuipers E; Dunn G; Bebbington PE; Fowler D; Freeman D
Schizophr Res; 2008 Mar; 100(1-3):53-9. PubMed ID: 18083007
[TBL] [Abstract][Full Text] [Related]
19. Involuntary admission from the patients' perspective.
O'Donoghue B; Lyne J; Hill M; Larkin C; Feeney L; O'Callaghan E
Soc Psychiatry Psychiatr Epidemiol; 2010 Jun; 45(6):631-8. PubMed ID: 19669680
[TBL] [Abstract][Full Text] [Related]
20. Indicators of medication compliance in first-episode psychosis.
Kampman O; Laippala P; Väänänen J; Koivisto E; Kiviniemi P; Kilkku N; Lehtinen K
Psychiatry Res; 2002 May; 110(1):39-48. PubMed ID: 12007592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
